Peptides

Selank: Anti-Anxiety Peptide — Effects, Research, and Dosage

Medically reviewed by Medical Advisory Board Last reviewed 2026-05-13

The Russian anxiolytic peptide that modulates GABA without dependence risk

Selank is a synthetic heptapeptide developed from the naturally occurring tetrapeptide tuftsin, used clinically in Russia for anxiety, stress, and cognitive support. It modulates GABAergic activity and reduces anxiety without the tolerance or dependence risk of benzodiazepines.

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analog of tuftsin, a naturally occurring immune peptide. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same group that developed semax, and received regulatory approval in Russia in the 2000s as a treatment for anxiety disorders.

Selank stands out among anxiolytic peptides because it modulates GABA, the brain's primary inhibitory neurotransmitter, through a mechanism different from that of benzodiazepines, without the tolerance development, dependence potential, and cognitive impairment that make benzos problematic for long-term use. Its tuftsin-like activity also gives it immunomodulatory properties.

Partner · Opt Health

Want peptides prescribed and monitored properly?

If you're considering peptide therapy, the difference between a clinical program and a gray-market vial is supervision. Opt Health prescribes peptides through licensed physicians with baseline labs and follow-up testing.

See Opt Health's peptide program →

Selank Effects and Mechanisms

GABAergic modulation: Selank enhances GABAergic tone, producing anxiolytic effects comparable to benzodiazepines in animal models — without causing tolerance or dependence.
Serotonin metabolism: Modulates serotonin turnover in limbic structures, contributing to mood stabilization.
BDNF effects: Like semax, selank shows some BDNF upregulation, supporting neuroprotection alongside anxiolytic effects.
Enkephalin degradation inhibition: Inhibits the enzymes that break down enkephalins (endogenous opioid peptides involved in pain and mood), which may contribute to mood-stabilizing effects.
Immune modulation: Through its tuftsin-like activity, selank modulates cytokine production and immune cell function.
Cognitive preservation: Unlike benzodiazepines, which impair memory consolidation, selank appears to preserve or slightly enhance cognitive function alongside anxiolytic effects.

Selank vs Semax: Key Differences

Factor	Selank	Semax
Primary effect	Anxiolytic, stress reduction	Cognitive enhancement, focus
GABA modulation	Strong	Minimal
BDNF upregulation	Moderate	Strong
Stimulating quality	Calming	Stimulating
Best for	Anxiety, stress, sleep, calm focus	Acute focus, BDNF, neuroprotection
Stacking	Often combined with semax for balanced cognitive support	Often combined with selank

Many users stack selank and semax together for balanced cognitive support — selank provides anxiolytic calm while semax provides stimulating cognitive enhancement and BDNF upregulation.

Selank Dosage

Standard selank protocols:

Intranasal: 250–750 mcg per day (most common route; available as 0.15% solution)
Injectable: 250–500 mcg subcutaneously per day
Timing: Morning use common for daytime anxiety/stress management; some use pre-sleep for sleep quality
Cycle: 2–4 weeks on, 1–2 weeks off

Frequently Asked Questions

What is selank?

Selank is a synthetic heptapeptide derived from tuftsin (a natural immune peptide), developed in Russia in the 1980s and approved there for clinical use as an anxiolytic. It reduces anxiety by modulating GABAergic activity without the tolerance, dependence, or cognitive impairment associated with benzodiazepines.

What does selank do?

Selank reduces anxiety and stress through GABAergic modulation, stabilizes mood by influencing serotonin turnover, provides mild neuroprotection through BDNF upregulation, and modulates immune function through tuftsin-like activity. Unlike benzodiazepines, it doesn't impair memory or cause dependence.

How much selank should I take?

Standard selank dosage in research protocols: 250–750 mcg intranasally per day, or 250–500 mcg subcutaneously. Most users start at the lower end and titrate based on response. Typical cycles are 2–4 weeks with breaks to prevent tolerance. This is for research reference only — not medical advice.

Topic updates

Get the weekly peptide roundup

Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.

Want peptide therapy handled by a physician who works from your labs? See how Opt Health does it →

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

Check Where You Stand

Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results